We are live on ! Find out more
AC

Alley Company Portfolio holdings

AUM $631M
1-Year Est. Return 24.9%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+24.9%
3 Year Est. Return
+88.19%
5 Year Est. Return
+123.98%
10 Year Est. Return
AUM
$228M
AUM Growth
+$3.3M
Cap. Flow
-$434K
Cap. Flow %
-0.19%
Top 10 Hldgs %
28.65%
Holding
81
New
4
Increased
21
Reduced
41
Closed
3

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$2.65M
2
NKE icon
Nike
NKE
+$1.64M
3
XOM icon
ExxonMobil
XOM
+$1.45M
4
CVS icon
CVS Health
CVS
+$1.42M
5
KMB icon
Kimberly-Clark
KMB
+$709K

Sector Composition

Rank Sector Weight
1 Financials 14.37%
2 Technology 11.87%
3 Healthcare 9.87%
4 Consumer Staples 8.83%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VPL icon
76
Vanguard FTSE Pacific ETF
VPL
$8.42B
$245K 0.11%
4,219
+230
+6% +$13.7K
PDCO
77
DELISTED
Patterson Companies, Inc.
PDCO
$239K 0.11%
5,821
GFA
78
DELISTED
Gafisa S.A.
GFA
$13K 0.01%
890
IBB icon
79
iShares Biotechnology ETF
IBB
$9.72B
-27,513
Closed -$2.65M
NKE icon
80
Nike
NKE
$62.4B
-31,115
Closed -$1.64M
XLRE icon
81
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.6B
-13,819
Closed -$453K

Similar funds

Alley Company's Q4 2016 Portfolio in Review

As of Q4 2016, Alley Company held 81 positions worth $228M, up 1.5% from $224M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Alley Company's Q4 2016 filing shows 4 new, 21 increased, 41 reduced and 3 closed positions. Its largest new stake was Broadridge: 46,952 shares worth $3.11M. The largest sale was iShares Biotechnology ETF, an estimated $2.65M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

  • Alley Company's largest Q4 2016 buy was Broadridge: 46,952 shares worth $3.11M.
  • Alley Company added most to Union Pacific in Q4 2016, an estimated $1.14M increase.
  • Alley Company's biggest Q4 2016 reduction was ExxonMobil, cutting an estimated $1.45M.
  • Alley Company fully exited iShares Biotechnology ETF in Q4 2016, selling an estimated $2.65M.
  • Alley Company's ten largest holdings make up 29% of its $228M portfolio in Q4 2016.
  • Alley Company opened 4 new positions and closed 3 in Q4 2016.
  • Alley Company's portfolio value rose 1.5% quarter-over-quarter to $228M.

Based on Alley Company's 13F filing for Q4 2016, filed 2 Feb 2017.